STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[8-K] Glaukos Corporation Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

Glaukos Corporation disclosed that it will present an investor presentation attached as Exhibit 99.1 to this Current Report and that the presentation will be made available on the company’s investor website. The company states the presentation may be used in investor and stakeholder meetings and that the information in Item 7.01 and Exhibit 99.1 is not intended to be deemed filed under the Exchange Act or incorporated by reference in other filings unless explicitly stated.

The report also lists an interactive cover page data file as Exhibit 104. No financial statements, earnings data, or material transactions are included in this filing.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Routine Regulation FD disclosure attaching an investor presentation; no new financial data or material transactions disclosed.

This 8-K is a standard investor-relations filing indicating management will use an attached investor presentation in outreach. It confirms availability on the company investor site and includes the customary legal proviso that the presentation is not "filed" or incorporated by reference. From a financial-analysis perspective, there is no new quantitative information to update models or valuation assumptions, so the immediate market impact is likely neutral and the filing is not impactful.

TL;DR: Governance disclosure following Regulation FD norms; provides transparency on investor communications without creating filing obligations.

The company follows expected governance practice by formally disclosing materials used in investor communications and clarifying their filing status. The attachment of Exhibit 99.1 and an Inline XBRL cover page (Exhibit 104) demonstrates procedural compliance. There are no governance concerns raised by the content itself; this is administrative and not impactful for corporate control or regulatory risk assessments.

0001192448false00011924482025-08-122025-08-12

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 12, 2025

Glaukos Corporation

(Exact name of registrant as specified in its charter)

Delaware

    

001-37463

    

33-0945406

(State or other jurisdiction

(Commission

(I.R.S. Employer

of incorporation)

File Number)

Identification No.)

One Glaukos Way
Aliso Viejo, California

    

92656

(Address of principal executive offices)

 

(Zip Code)

Registrant’s telephone number, including area code: (949) 367-9600

Not Applicable

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).  Emerging growth company 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  

Securities registered pursuant to Section 12(b) of the Act:

Title of each class:

    

Trading Symbol

    

Name of each exchange on which registered:

Common Stock

GKOS

New York Stock Exchange

Item 7.01. Regulation FD Disclosure.

Glaukos Corporation (the “Company”) intends to present the materials attached as Exhibit 99.1 to this Current Report on Form 8-K (the “Investor Presentation”) from time to time in presentations to investors and other stakeholders. The Investor Presentation will also be available on the investor page of the Company’s website at http://investors.glaukos.com.

The information contained in this Item 7.01 and in the accompanying Exhibit 99.1 shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.

    

Description

99.1

 

Investor Presentation, dated August 2025

104

Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

GLAUKOS CORPORATION
(Registrant)  

 

By:

 /s/ Alex R. Thurman

 

 

Name:     Alex R. Thurman

 

 

Title:       Senior Vice President & Chief Financial Officer

Date: August 12, 2025

FAQ

What does Glaukos's 8-K (GKOS) report?

The 8-K states the company will present an Investor Presentation attached as Exhibit 99.1 and that the presentation will be available on its investor website.

Is the Investor Presentation considered filed with the SEC?

No. The company explicitly states the information in Item 7.01 and Exhibit 99.1 is not deemed filed under the Exchange Act and is not incorporated by reference unless expressly stated.

Where can investors find the presentation referenced in the 8-K?

The filing says the Investor Presentation will be available on Glaukos's investor page at http://investors.glaukos.com.

Does the 8-K include financial statements or earnings data?

No. The filing contains an investor presentation exhibit and an interactive cover page data file but does not include financial statements or earnings figures.

What exhibits are attached to this 8-K for GKOS?

Exhibit 99.1 is the Investor Presentation and Exhibit 104 is the Cover Page Interactive Data File embedded in the Inline XBRL document.
Glaukos Corp

NYSE:GKOS

GKOS Rankings

GKOS Latest News

GKOS Latest SEC Filings

GKOS Stock Data

4.94B
55.53M
3.31%
107.34%
5.9%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
ALISO VIEJO